Following the recommendations of the authorities for the coronavirus pandemic, SARA Pharm has taken the necessary measures to ensure the continuity of its activity. The current projects are on-going. The laboratory is operational and the necessary precautions have been taken to allow the safe reception of samples. We do not foresee any impact on our activity to date. In the event of an evolution, we will not fail to keep you informed.

September 30th, 2013

SARA Pharm Solutions has received European and National funding to develop nanostructured materials withelectrocatalytic activity. The name of the project is SARELCAT and its website can be accessed here.